FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * New Enterprise Associates 14, L.P. 2. Issuer Name and Ticker or Trading Symbol CHAMPIONS ONCOLOGY, INC. [ CSBR ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
1954 GREENSPRING DRIVE, SUITE 600
3. Date of Earliest Transaction (MM/DD/YYYY)
3/6/2020
(Street)
TIMONIUM, MD 21093
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  3/6/2020    X    859375  A $5.76  2421875  D (1)  
Common Stock  3/6/2020    S(2)    708155  D $6.99  1713720  D (1)  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant to Purchase Common Stock (right to buy)  $5.76  3/6/2020    X        859375   3/13/2015  3/13/2020  Common Stock  859375  $0.00  0  D (1)  

Explanation of Responses:
(1)  The securities are directly held by New Enterprise Associates 14, L.P. ("NEA 14") and are indirectly held by NEA Partners 14, L.P. ("NEA Partners 14"), the sole general partner of NEA 14, NEA 14 GP, LTD ("NEA 14 LTD"), the sole general partner of NEA Partners 14 and each of the individual directors of NEA 14 LTD (NEA Partners 14, NEA 14 LTD and the individual directors of NEA 14 LTD (collectively, the "Directors") together, the "Indirect Reporting Persons"). The Directors of NEA 14 LTD are Forest Baskett, Anthony A. Florence, Jr., Patrick J. Kerins, Scott D. Sandell and Peter Sonsini. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 securities in which the Indirect Reporting Persons have no pecuniary interest.
(2)  On March 6, 2020, NEA 14 exercised a warrant to purchase a total of 859,375 shares of Issuer's common stock for $5.76 a share. NEA 14 paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 708,155 of the warrant shares to pay the exercise price and issuing 151,220 shares to NEA 14.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
New Enterprise Associates 14, L.P.
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM, MD 21093

X

Sonsini Peter W.
2855 SAND HILL ROAD
MENLO PARK, CA 94025

X

Florence Anthony A. Jr.
5425 WISCONSIN AVENUE, SUITE 800
CHEVY CHASE, MD 20815

X

BASKETT FOREST
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM, MD 21093

X

KERINS PATRICK J
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM, MD 21093

X

NEA 14 GP, LTD
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM, MD 21093

X

NEA Partners 14, L.P.
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM, MD 21093

X

SANDELL SCOTT D
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM, MD 21093

X


Signatures
/s/ Sasha Keough, attorney in fact 3/10/2020
**Signature of Reporting Person Date
Champions Oncology (NASDAQ:CSBR)
Historical Stock Chart
From Aug 2020 to Sep 2020 Click Here for more Champions Oncology Charts.
Champions Oncology (NASDAQ:CSBR)
Historical Stock Chart
From Sep 2019 to Sep 2020 Click Here for more Champions Oncology Charts.